Join the Weight Loss (Obesity / Overweight) group to help and get support from people like you.
Weight Loss (Obesity / Overweight) News (Page 17)
Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications
New Treatment Modality May Reduce Obesity in Schizophrenia Patients
FRIDAY, Nov. 17, 2023 – In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31...
Experimental Weight-Loss Drug, Retatrutide, Slashed Fat in Livers of Obese People
WEDNESDAY, Nov. 15, 2023 – Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new...
AHA: Semaglutide Cuts Risk for CVD Events in Patients Without Diabetes
MONDAY, Nov. 13, 2023 – Weekly subcutaneous semaglutide significantly cuts the incidence of cardiovascular death and nonfatal heart attacks and strokes in adults with preexisting cardiovascular...
Science Reveals Link Between Obesity, Diabetes & Pancreatic Cancer Risk
FRIDAY, Nov. 10, 2023 – Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer. In the study,...
FDA Investigating Hospitalizations Linked to Counterfeit Ozempic
WEDNESDAY, Nov. 8, 2023 – The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of semaglutide. At least one of...
FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro
THURSDAY, Nov. 9, 2023 – A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The...
Yoga Intervention Can Reduce Felt Stigma in Epilepsy Patients
THURSDAY, Nov. 9, 2023 – For patients with epilepsy, yoga therapy plus psychoeducation can reduce felt stigma, according to a study published online Nov. 8 in Neurology. Kirandeep Kaur, Ph.D., from...
FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro
WEDNESDAY, Nov. 8, 2023 – A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The...
FDA Investigating Hospitalizations Linked to Counterfeit Ozempic
WEDNESDAY, Nov 8, 2023 – The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss...
Tirzepatide Tied to Substantial Additional Weight Loss After Lifestyle Intervention
WEDNESDAY, Nov. 8, 2023 – Tirzepatide provides substantial additional reduction in body weight in participants who already achieved ≥5.0 percent weight reduction with an intensive lifestyle i...
FDA Approves Zepbound (tirzepatide) for Chronic Weight Management
INDIANAPOLIS, Nov. 8, 2023 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and only obesity t...
Doctors: Want Patients to Lose Weight? Stay Upbeat
TUESDAY, Nov. 7, 2023 – When doctors advise patients to lose weight, an optimistic approach is more likely to get results. Researchers found that patients were more likely to participate in the...
Presenting Weight Loss Treatment as Positive Opportunity Is Beneficial
TUESDAY, Nov. 7, 2023 – For patients with obesity seeing a general practitioner, presenting weight loss treatment as a positive opportunity is associated with increased uptake of treatment and more...
Time-Restricted Eating Effective for Weight Loss, Lowering HbA1c
THURSDAY, Nov. 2, 2023 – A time-restricted eating (TRE) intervention without calorie counting is effective for weight loss and lowering hemoglobin A1c (HbA1c) levels among adults with obesity and...
Metformin May Help Young Patients With Bipolar Disorder Avoid Weight Gain
TUESDAY, Oct. 31, 2023 – Taking the drug metformin – typically used for type 2 diabetes – can help counter weight gain in young people who are taking medication for bipolar disorder, according to a n...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
bupropion, phentermine, Contrave, amphetamine, Saxenda, methamphetamine, topiramate, Wegovy, Mounjaro, view more... methylphenidate, Qsymia, semaglutide, Adipex-P, Alli, liraglutide, orlistat, garcinia cambogia, desvenlafaxine